Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 3/2003

01-05-2003 | Case Report

Peripheral T cell lymphoma-associated hemophagocytic syndrome in a patient with human adjuvant disease

Authors: Masao Negishi, Tsuyoshi Kasama, Ryosuke Hanaoka, Hirotsugu Ide, Shigeko Inokuma

Published in: Rheumatology International | Issue 3/2003

Login to get access

Abstract

Hemophagocytic syndrome (HPS) is a rare complication of lymphoma. We report a 70-year-old woman with human adjuvant disease who developed lymphoma-associated HPS (LAHPS) and elevated serum soluble interleukin (IL)-2 receptor. Despite intensive therapy, she died of pneumonia. Necropsy revealed a prominent spleen containing atypical T cells and many erythrophagocytizing histiocytes.
Literature
1.
Risdall RJ, McKenna RW, Nesbit ME (1979) Virus-associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993–1002PubMed
2.
Wong KF, Hui PK, Chan JLC (1991) The acute lupus hemophagocytic syndrome. Ann Int Med 114: 387–390
3.
Negishi M, Kasama T, Iwabuchi H, Kanemitsu H, Ide H (2002) Autoimmune-associated hemophagocytic syndrome in a patient with rheumatoid arthritis. Clin Rheumatol 21: 87–88PubMed
4.
Miyoshi K, Miyaoka T, Kobayashi Y (1964) Hypergammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty. Ijishimpo 2122: 9–14
5.
Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA (1990) Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 66: 530–536PubMed
6.
Falini B, Pileri S, De Solas I, Martelli MF, Mason DY, Delsol G, Gatter KC, Fagioli M (1990) Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75: 434–444PubMed
Metadata
Title
Peripheral T cell lymphoma-associated hemophagocytic syndrome in a patient with human adjuvant disease
Authors
Masao Negishi
Tsuyoshi Kasama
Ryosuke Hanaoka
Hirotsugu Ide
Shigeko Inokuma
Publication date
01-05-2003
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2003
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-002-0281-0

Other articles of this Issue 3/2003

Rheumatology International 3/2003 Go to the issue

Case Report

A challenging case of rheumatoid arthritis in an acromegalic patient

Original Article

Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritis

Original Article

Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis

Original Article

Polymorphism of the Duffy erythrocyte chemokine receptor in Italian patients with Behçet's disease

Original Article

Polymorphism of the β3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine

Original Article

Functional disability and quality of life in patients with ankylosing spondylitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits